Imaging E-selectin expression following traumatic brain injury in the rat using a targeted USPIO contrast agent. - Archive ouverte HAL Access content directly
Journal Articles Magnetic Resonance Materials in Physics, Biology and Medicine Year : 2009

Imaging E-selectin expression following traumatic brain injury in the rat using a targeted USPIO contrast agent.

(1) , (2) , (1) , (1) , (1) , (1) , (1) , (1)
1
2

Abstract

INTRODUCTION: The aim of this work was to map E-selectin expression in a traumatic brain injury model using a newly-designed MR contrast agent. Iron cores, responsible for susceptibility effects and therefore used as T2* contrast agents, need to be coated in order to be stabilized and need to be targeted to be useful. METHODS: We have designed a molecule coating composed, at one end, of bisphosphonate to ensure anchorage of the coating on the iron core and, at the other end, of Fukuda's defined heptapeptide known to target selectin binding sites. CONCLUSION: The synthesized nanoparticles were able to non-invasively target the traumatic brain lesion, inducing a specific T2* decrease of about 25% up to at least 70 min post-injection of the targeted contrast agent.
Fichier principal
Vignette du fichier
table1_selectin.pdf (10.07 Ko) Télécharger le fichier
Vignette du fichier
chapon_2009.pdf (164.44 Ko) Télécharger le fichier
Vignette du fichier
inserm-00353311_edited.pdf (288 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)
Origin : Files produced by the author(s)

Dates and versions

inserm-00353311 , version 1 (04-01-2010)

Identifiers

Cite

Catherine Chapon, Florence Franconi, Franck Lacoeuille, François Hindré, Patrick Saulnier, et al.. Imaging E-selectin expression following traumatic brain injury in the rat using a targeted USPIO contrast agent.. Magnetic Resonance Materials in Physics, Biology and Medicine, 2009, 22 (3), pp.167-74. ⟨10.1007/s10334-008-0161-z⟩. ⟨inserm-00353311⟩

Collections

INSERM UNIV-ANGERS
199 View
787 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More